Literature DB >> 23867596

Characterization of acute heart failure hospitalizations in a Portuguese cardiology department.

Ana Catarina Pinho-Gomes1, José Silva Cardoso, Luís Filipe Azevedo, Rui Almeida, Teresa Pinho, Maria Júlia Maciel.   

Abstract

INTRODUCTION AND AIMS: We describe the clinical characteristics, management and outcomes of patients hospitalized with acute heart failure in a south-west European cardiology department. We sought to identify the determinants of length of stay and heart failure rehospitalization or death during a 12-month follow-up period. METHODS AND
RESULTS: This was a retrospective cohort study including all patients admitted during 2010 with a primary or secondary diagnosis of acute heart failure. Death and readmission were followed through 2011. Of the 924 patients admitted, 201 (21%) had acute heart failure, 107 (53%) of whom had new-onset acute heart failure. The main precipitating factors were acute coronary syndrome (63%) and arrhythmia (14%). The most frequent clinical presentations were heart failure after acute coronary syndrome (63%), chronic decompensated heart failure (47%) and acute pulmonary edema (21%). On admission 73% had left ventricular ejection fraction <50%. Median length of stay was 11 days and in-hospital mortality was 5.5%. The rehospitalization rate was 21% and 24% at six and 12 months, respectively. All-cause mortality was 16% at 12 months. The independent predictors of rehospitalization or death were heart failure hospitalization during the previous year (Hazard ratio - HR - 3.177), serum sodium <135mmol/l on admission (HR 1.995) and atrial fibrillation (HR 1.791). Reduced left ventricular ejection fraction was associated with a lower risk of rehospitalization or death (HR 0.518).
CONCLUSIONS: Our patients more often presented new-onset acute heart failure, due to an acute coronary syndrome, with reduced left ventricular ejection fraction. Several predictive factors of death or rehospitalization were identified that may help to select high-risk patients to be followed in a heart failure management program after discharge.
Copyright © 2012 Sociedade Portuguesa de Cardiologia. Published by Elsevier España. All rights reserved.

Entities:  

Keywords:  Acute coronary syndrome; Acute heart failure; Duração de internamento; Insuficiência cardíaca aguda; Length of stay; Management; Mortalidade; Mortality; Prognosis; Prognóstico; Re-hospitalization; Rehospitalização; Síndrome coronária aguda; Tratamento

Mesh:

Year:  2013        PMID: 23867596     DOI: 10.1016/j.repc.2012.10.018

Source DB:  PubMed          Journal:  Rev Port Cardiol        ISSN: 0870-2551            Impact factor:   1.374


  3 in total

1.  Time-pattern of adverse outcomes after an infection-triggered acute heart failure decompensation and the influence of early antibiotic administration and hospitalisation: results of the PAPRICA-3 study.

Authors:  Òscar Miró; Koji Takagi; Étienne Gayat; Víctor Gil; Pere Llorens; Francisco J Martín-Sánchez; Javier Jacob; Pablo Herrero-Puente; Rosa Escoda; María Pilar López-Díez; Amparo Valero; Marta Fuentes; José M Garrido; Eva Salvo; Miguel A Rizzi; Alfons Aguirre; Lissete Travería Bécquer; Alberto Domínguez-Rodríguez; Joan Padrosa; Gemma Martínez; Mattia Arrigo; Yonathan Freund; Alexandre Mebazaa
Journal:  Clin Res Cardiol       Date:  2019-04-29       Impact factor: 5.460

2.  The cardiac care bridge program: design of a randomized trial of nurse-coordinated transitional care in older hospitalized cardiac patients at high risk of readmission and mortality.

Authors:  L Verweij; P Jepma; B M Buurman; C H M Latour; R H H Engelbert; G Ter Riet; F Karapinar-Çarkit; S Daliri; R J G Peters; W J M Scholte Op Reimer
Journal:  BMC Health Serv Res       Date:  2018-06-28       Impact factor: 2.655

3.  Management, survival, and predictors of mortality among hospitalized heart failure patients at Debre Markos comprehensive specialized hospital, Northwest Ethiopia: Prospective cohort study.

Authors:  Bekalu Kebe; Melese Getachew; Yalew Molla; Bereket Bahiru; Bekalu Dessie
Journal:  SAGE Open Med       Date:  2021-11-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.